Abstract
Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 163-166 |
| Numero di pagine | 4 |
| Rivista | Aging clinical and experimental research |
| Volume | 18 |
| Stato di pubblicazione | Published - 2006 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.1300.1302???
- ???subjectarea.asjc.2700.2717???